THE COST-EFFECTIVENESS OF THREE PREVENTION STRATEGIES IN ALZHEIMER'S DISEASE: RESULTS FROM THE MULTIDOMAIN ALZHEIMER PREVENTIVE TRIAL (MAPT) • The Journal of Prevention of Alzheimer's Disease
PDF) Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: Results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study)
8 remèdes au prix élevé des médicaments | Paperjam News
Hepatitis B or Delta liver transplant patients at risk of recurrence: Long-term effectiveness and budget impact of low-dose subcutaneous anti-hepatitis B immunoglobulin plus patient education program - ScienceDirect
utilisation des médicaments dans les maisons de soins - KCE
Full article: A comparative public health and budget impact analysis of pneumococcal vaccines: The French case
POMME: The New Cohort to Evaluate Long-Term Effects After Prenatal Medicine Exposure | SpringerLink
Cost-utility analysis of atezolizumab with bevacizumab in untreated unresectable or advanced hepatocellular carcinoma in France | PLOS ONE
Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from France - Erin Johansson, Anders Gustavsson, Carolin Miltenburger, Korinna Karampampa, Lucien Rumbach, Karin Rérat, Celine Thonnelier, 2012
Cost-effectiveness of TLC-NOSF dressings versus neutral dressings for the treatment of diabetic foot ulcers in France | PLOS ONE
Competition From Biosimilars Drives Price Reductions For Biologics In The French Single-Payer Health System | Health Affairs
Réforme de l'accès dérogatoire aux médicaments (MAJ 24/04/23) - OMEDIT Ile de France
Cost-effectiveness of TLC-NOSF dressings versus neutral dressings for the treatment of diabetic foot ulcers in France | PLOS ONE
La base de données médicaments Thériaque - CNHIM
Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from France - Erin Johansson, Anders Gustavsson, Carolin Miltenburger, Korinna Karampampa, Lucien Rumbach, Karin Rérat, Celine Thonnelier, 2012
Hepatitis B or Delta liver transplant patients at risk of recurrence: Long-term effectiveness and budget impact of low-dose subcutaneous anti-hepatitis B immunoglobulin plus patient education program - ScienceDirect
Marge sur les médicaments - Comparaison avec l'étranger, Conférence de presse santésuisse, 23 novembre 2011
Vaccines | Free Full-Text | Budget Impact Analysis of Fixed Dose Versus Weight-Based Dosing Regimen of Nivolumab and Pembrolizumab in the Treatment of Non-Small Cell Lung Cancer
CIP ACL - Nouvelle version des bases de données avril 2019
OFFRE D'EMPLOI : Responsable Technico-Commercial en Transit (H/F) - Africa Supply Chain
Should We Prevent Off-Label Drug Prescriptions? Empirical Evidence from France”
